Image by freepik The composition of gut bacteria can predict which melanoma patients will experience cancer recurrence after surgical resection and immunotherapy, but only when matched to patients with similar microbial profiles, according to research published April 17 in Cell. The findings from a 674-patient international clinical trial offer a novel approach to stratifying recurrence risk in high-risk melanoma patients undergoing adjuvant immune checkpoint blockade. Resear

A newly published study from NYU Langone Health and the Perlmutter Cancer Center suggests a promising avenue of treatment for patients...

Researchers at NYU Langone Health and its Perlmutter Cancer Center have developed a remote diagnostic tool, SpotCheck, which demonstrates...

A study by researchers at NYU Langone Health has identified a critical biological pathway driving inflammation in psoriasis, potentially...

Two new and highly contagious fungal infections that cause difficult-to-treat skin rashes are prompting experts to alert healthcare...

Phase III studies of a personalized vaccine plus immunotherapy for melanoma have been launched at cancer centres around the world,...

When melanoma cells metastasize to the brain, the malignant cells depend on the protein amyloid beta to survive and spread, according to...

A retrospective study of an insurance database in the U.S. has revealed patients with acne who were prescribed isotretinoin were less...